Abstract
Breast cancer is one of the most prevalent cancers in women; about one in eight women will be affected by it. Also, it is one of the leading causes of death in women. It is critical to get involved in breast screening to enable early detection with consequent decreased morbidity and mortality associated with breast cancer.
Screening mammography is estimated to reduce breast cancer mortality by almost 40% if performed on an annual basis rather than less frequently. Screening for breast cancer can also involve ultrasound and MRI depending on the age and individualized risk for a patient.
Imaging for breast cancer involves screening as well as diagnostic modalities. BI-RADS (breast imaging-reporting and data system) categories are used to categorize breast imaging reports. The diagnosis of breast cancer is established with the use of image-guided biopsies involving ultrasound, stereotactic guidance, and MRI. These also play a critical role in treatment planning and monitoring.
The following discussion will elaborate on the different imaging modalities used for the screening and diagnosis of breast cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lee SC, Jain PA, Jethwa SC, Tripathy D, Yamashita MW. Radiologist’s role in breast cancer staging: providing key information for clinicians. Radiographics. 2014;34(2):330–42.
Chen L, Chantra PK, Larsen LH, Barton P, Rohitopakarn M, Zhu EQ, et al. Imaging characteristics of malignant lesions of the male breast. Radiographics. 2006;26(4):993–1006.
Broeders M, Moss S, Nyström L, Njor S, Jonsson H, Paap E, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen. 2012;19(Suppl 1):14–25.
Chen W. Patient education: factors that modify breast cancer risk in women (beyond the basics). https://www.uptodate.com.
Nicholson BT, Harvey JA, Cohen MA. Nipple-areolar complex: normal anatomy and benign and malignant processes. Radiographics. 2009;29(2):509–23.
American College of Radiology. Benefits and limitations of mammography. Digest of Council Action 2015-2016: 2002, amended 2012 (Res. 23-c).
Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, et al. Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst. 2014;106(11)
Helquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordás P, Tabár L, et al. Effectiveness of population-based service screening with mammography for women ages 40-49 years. Cancer. 2010;117(4):714–22.
Helvie MA, Chang JT, Hendrick RE, Banerjee M. Reduction in late-stage breast cancer incidence in the mammography era. Cancer. 2014;120(17):2649–56.
Koroukian SM, Bakaki PM, Htoo PT, Han X, Schluchter M, Owusu C, et al. The breast and cervical cancer early detection program, medicaid, and breast cancer outcomes among Ohio’s underserved women. Cancer. 2017;123(16):3097–106.
Hendrick RE, Helvie MA. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death. AJR Am J Roentgenol. 2012;198:723–8.
Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2014. https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017. Bethesda, MD: National Cancer Institute; 2017.
Grady D, Redberg R. Physician adherence to breast cancer screening recommendations. JAMA Intern Med. 2017;177(6):763–4.
Berg W, Mendelson EB, Merritt CB. ACRIN 6666: screening breast ultrasound in high risk women. https://www.acrin.org/portals/0/protocols/6666/a6666partial_summary.pdf.
Kennedy DA, Lee T, Seely D. A comparative review of thermography as a breast cancer screening technique. Integr Cancer Ther. 2009;8(1):9–16.
Gautherie M. Thermobiological assessment of benign and malignant breast diseases. Am J Obstet Gynecol. 1983;147(8):861–9.
Alcantara D, Leal MP, Garcia-Bocanegra I, Garcia-Martin ML. Molecular imaging of breast cancer: present and future directions. Front Chem. 2014;2:112.
O’Connor MK. Molecular breast imaging: an emerging modality for breast cancer screening. Breast Cancer Manag. 2015;4(1):33–40.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Singh, H. (2019). Breast Cancer: Role of Imaging. In: Mehta, S., Singla, A. (eds) Preventive Oncology for the Gynecologist. Springer, Singapore. https://doi.org/10.1007/978-981-13-3438-2_27
Download citation
DOI: https://doi.org/10.1007/978-981-13-3438-2_27
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3437-5
Online ISBN: 978-981-13-3438-2
eBook Packages: MedicineMedicine (R0)